Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Red Grape

What does the research say about Red Grape?

4 health outcomes synthesised

Red grape extract, particularly grape seed extract, has been researched for its potential effects on cardiovascular and liver health, with studies across 4 health outcomes including blood pressure and liver enzyme levels. The strongest evidence supports a small beneficial effect on reducing diastolic blood pressure, based on 4 studies showing consistent positive results in hypertensive and metabolic syndrome populations. The most commonly studied dose is 520 mg/day of grape seed extract, though generalizability to whole grape or juice products remains unclear.

Strongest evidence: The most consistent findings are for reduced diastolic blood pressure (moderate evidence strength) and reduced aspartate aminotransferase (AST) levels (moderate evidence strength). For diastolic blood pressure, all 4 studies reported small beneficial effects, primarily in individuals with hypertension or metabolic syndrome, with a median study duration of 34 days and a reported dose of 520 mg/day in one trial. For AST, 3 of 4 studies found small beneficial effects in NAFLD and thalassemia patients over a median of 44 days (doses ranging 100–520 mg/day).

Mixed or weaker evidence: Evidence for reduced systolic blood pressure (low evidence strength) is mixed, with 2 of 3 studies showing small beneficial effects and 1 neutral result in a 7-day trial of males with elevated blood pressure. For reduced alanine aminotransferase (ALT) levels (low evidence strength), 2 of 3 studies reported small-to-moderate beneficial effects in NAFLD patients, while 1 neutral study used quercetin in a thalassemia population, suggesting effects may be form- or population-specific.

Effective dose patterns: When specified, 520 mg/day of grape seed extract appears across multiple outcomes (diastolic blood pressure, systolic blood pressure, ALT reduction) as the most common effective dose, typically administered over 60 days. However, dosing was incompletely reported in many studies, and no effective dose was stated for AST reduction.

Population insights: Research primarily targets clinical populations — individuals with hypertension, metabolic syndrome, or non-alcoholic fatty liver disease (NAFLD). Effects are less clear in healthy or general populations. One study in males with elevated stage 1 hypertension showed neutral effects on systolic blood pressure over a short 7-day period, suggesting short-term use may be insufficient.

Notable caveats: The evidence base is small across all outcomes (3–4 studies each), and conclusions are preliminary. Publication bias is a concern, as null-result studies are less likely to be published. Most studies used grape seed extract, not whole grape or juice, limiting generalizability. Sample sizes were small (e.g., n=25–30 in RCTs), and study durations were short (7–60 days). One neutral study used quercetin or curcumin instead of red grape extract, complicating comparability.

Frequently asked

  • What is Red Grape good for according to research?
    Research suggests red grape extract, particularly grape seed extract, may have small beneficial effects on reducing diastolic blood pressure (4 studies, moderate evidence) and aspartate aminotransferase (AST) levels (3 of 4 studies, moderate evidence) in clinical populations such as those with hypertension or NAFLD. Evidence for systolic blood pressure and ALT levels is weaker and more mixed.
  • What dose of Red Grape is typically used in studies?
    The most commonly reported effective dose is 520 mg/day of grape seed extract, observed in studies on diastolic blood pressure, systolic blood pressure, and ALT reduction. Dosing varied widely across studies (100–520 mg/day), and many studies did not specify the dose, so no single dose can be generalized as standard.
  • Who benefits most from Red Grape?
    Beneficial effects have been observed primarily in clinical populations, including individuals with hypertension, metabolic syndrome, non-alcoholic fatty liver disease (NAFLD), and thalassemia with iron overload. Evidence in healthy or general populations is lacking.
  • Are there caveats or limitations in the research on Red Grape?
    Yes, the evidence base is small (3–4 studies per outcome), and conclusions are preliminary. Publication bias is a concern, as null results are less likely to be published. Most studies used grape seed extract, not whole red grape or juice, so results may not generalize. Study durations were short (7–60 days), and sample sizes were small (e.g., n=25–30).
  • Does Red Grape help with reducing diastolic blood pressure?
    Across 4 studies, all reported small beneficial effects of red grape extract (primarily grape seed extract) on reducing diastolic blood pressure, with moderate evidence strength. Effects were seen in hypertensive and metabolic syndrome populations over a median duration of 34 days, with 520 mg/day reported in one trial.
  • Does Red Grape help with reducing liver enzyme levels?
    For AST levels, 3 of 4 studies showed small beneficial effects (moderate evidence) in NAFLD and thalassemia patients over about 6 weeks. For ALT levels, 2 of 3 studies found small-to-moderate effects in NAFLD patients (low evidence), though one neutral study used quercetin rather than red grape extract, complicating the findings.

Most-studied combinations with Red Grape

most supplement research is combination research
Also studied with:Turmeric (2), Ginkgo (2), Thistle (2)
    Back to top